0.4 ML ofatumumab 50 MG/ML Pen Injector
- RxCUI
- 2390949
- RxNorm name
- 0.4 ML ofatumumab 50 MG/ML Pen Injector
- Display name
- 0.4 ML ofatumumab 50 MG/ML Pen Injector
- Full name
- 0.4 ML ofatumumab 50 MG/ML Pen Injector
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:02
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125326 | Arzerra | ofatumumab | 351(a) | Disc | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KESIMPTA | OFATUMUMAB | Novartis Pharmaceuticals Corporation | 6a8a3f53-2062-48ff-9dbe-b939df133ca3 | 2026-04-01 | Warnings, Adverse reactions | 2390949 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6a8a3f53-2062-48ff-9dbe-b939df133ca3 | ofatumumab 20 MG in 0.4 ML Pen Injector [PSN] · 0.4 ML ofatumumab 50 MG/ML Pen Injector [SCD] · ofatumumab 20 MG per 0.4 ML Pen Injector [SY] | 3 | 11 | These highlights do not include all the information needed to use KESIMPTA safely and effectively. See full prescribing information for KESIMPTA. KESIMPTA ® (ofatumumab) injection, for subcutaneous use Initial U.S. Approval: 2009 | 20260401 |